Cellular delivery of MRI contrast agents

被引:71
|
作者
Allen, MJ
MacRenaris, KW
Venkatasubramanian, PN
Meade, TJ
机构
[1] Northwestern Univ, Dept Chem Biochem & Mol & Cell Biol, Evanston, IL 60208 USA
[2] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA
[3] Northwestern Univ, Dept Radiol, Evanston, IL 60208 USA
[4] ENH Res Inst, Ctr Basic MR Res, Evanston, IL 60201 USA
来源
CHEMISTRY & BIOLOGY | 2004年 / 11卷 / 03期
关键词
D O I
10.1016/j.chembiol.2004.03.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Magnetic resonance imaging (MRI) is a powerful tool for acquiring images of opaque living animals with the benefit of tracking events over extended periods of time on the same specimen. Contrast agents are used to enhance regions, tissues, and cells that are magnetically similar but histologically distinct. A principal barrier to the development of MRI contrast agents for investigating biological questions is the delivery of agents across cellular membranes. Here, we describe the synthesis and in vitro testing of Gd(III)-based MRI contrast agents containing varying length polyarginine oligomers capable of permeating cell membranes. We examine the effect of the length of oligomer on T-1 enhancement and cellular uptake. Furthermore, the effect of incubation time, concentration, and cell type on uptake is explored. Toxicity and washout studies are performed in addition to MRI phantom studies.
引用
收藏
页码:301 / 307
页数:7
相关论文
共 50 条
  • [1] Contrast agents for functional and cellular MRI of the kidney
    Grenier, Nicolas
    Pedersen, Michael
    Hauger, Olivier
    EUROPEAN JOURNAL OF RADIOLOGY, 2006, 60 (03) : 341 - 352
  • [2] Ferritin: A Platform for MRI Contrast Agents Delivery
    Ruggiero, Maria Rosaria
    Alberti, Diego
    Bitonto, Valeria
    Crich, Simonetta Geninatti
    INORGANICS, 2019, 7 (03)
  • [3] Mechanisms for cellular uptake of nanosized clinical MRI contrast agents
    Guggenheim, Emily J.
    Rappoport, Joshua Z.
    Lynch, Iseult
    NANOTOXICOLOGY, 2020, 14 (04) : 504 - 532
  • [4] Functionalization of Clinically Approved MRI Contrast Agents for the Delivery of VEGF
    Bietenbeck, Michael
    Engel, Sabrina
    Lamping, Sebastian
    Hansen, Uwe
    Faber, Cornelius
    Ravoo, Bart Jan
    Yilmaz, Ali
    BIOCONJUGATE CHEMISTRY, 2019, 30 (04) : 1042 - 1047
  • [5] Glycopolymer contrast agents for fluorescence and MRI detection of DNA delivery
    Bryson, Joshua M.
    Fichter, Katye M.
    Lee, Jing-huei
    Chu, Wen-Jang
    Reineke, Theresa M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [6] Considerations for the clinical use of contrast agents for cellular MRI in regenerative medicine
    Modo, Michel
    Kolosnjaj-Tabi, Jelena
    Nicholls, Francesca
    Ling, Wen
    Wilhelm, Claire
    Debarge, Olivier
    Gazeau, Florence
    Clement, Olivier
    CONTRAST MEDIA & MOLECULAR IMAGING, 2013, 8 (06) : 439 - 455
  • [7] Contrast agents for MRI
    Emily A. Waters
    Samuel A. Wickline
    Basic Research in Cardiology, 2008, 103 : 114 - 121
  • [8] Contrast agents for MRI
    Shokrollahi, H.
    MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2013, 33 (08): : 4485 - 4497
  • [9] Contrast Agents in MRI
    Sobol, W. T.
    MEDICAL PHYSICS, 2008, 35 (06)
  • [10] Contrast agents for MRI
    Waters, Emily A.
    Wickline, Samuel A.
    BASIC RESEARCH IN CARDIOLOGY, 2008, 103 (02) : 114 - 121